- Home
- GH vs OMAB Comparison
GH vs OMAB Comparison
Compare GH & OMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- OMAB
- Stock Information
- Founded
- GH 2011
- OMAB 1998
- Country
- GH United States
- OMAB Mexico
- Employees
- GH N/A
- OMAB N/A
- Industry
- GH Medical Specialities
- OMAB Aerospace
- Sector
- GH Health Care
- OMAB Consumer Discretionary
- Exchange
- GH Nasdaq
- OMAB Nasdaq
- Market Cap
- GH 4.3B
- OMAB 3.5B
- IPO Year
- GH 2018
- OMAB 2006
- Fundamental
- Price
- GH $31.83
- OMAB $72.22
- Analyst Decision
- GH Strong Buy
- OMAB Buy
- Analyst Count
- GH 14
- OMAB 2
- Target Price
- GH $39.93
- OMAB $94.00
- AVG Volume (30 Days)
- GH 1.6M
- OMAB 100.7K
- Earning Date
- GH 11-06-2024
- OMAB 10-25-2024
- Dividend Yield
- GH N/A
- OMAB 12.15%
- EPS Growth
- GH N/A
- OMAB 2.12
- EPS
- GH N/A
- OMAB 0.66
- Revenue
- GH $692,256,000.00
- OMAB $748,989,666.00
- Revenue This Year
- GH $32.23
- OMAB N/A
- Revenue Next Year
- GH $16.90
- OMAB $7.13
- P/E Ratio
- GH N/A
- OMAB $13.57
- Revenue Growth
- GH 29.20
- OMAB 1.76
- 52 Week Low
- GH $15.81
- OMAB $59.08
- 52 Week High
- GH $38.53
- OMAB $90.53
- Technical
- Relative Strength Index (RSI)
- GH 45.64
- OMAB 57.41
- Support Level
- GH $34.20
- OMAB $71.39
- Resistance Level
- GH $36.24
- OMAB $74.63
- Average True Range (ATR)
- GH 1.70
- OMAB 2.29
- MACD
- GH -0.92
- OMAB 0.33
- Stochastic Oscillator
- GH 15.98
- OMAB 76.71
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park.